TY - JOUR
AU - Wendland, F.
AU - Berthold, G.
AU - Fritsche, J.-G.
AU - Herrmann, F.
AU - Kunkel, R.
AU - Voigt, H.-J.
AU - Vereecken, H.
TI - A conceptual hydrogeological model for evaluating residence times in Hessen
JO - Grundwasser
VL - 16
SN - 1430-483X
CY - Berlin
PB - Springer
M1 - PreJuSER-17016
SP - 163 - 176
PY - 2011
N1 - Record converted from VDB: 12.11.2012
AB - The association between long-term use of depot-medroxyprogesterone acetate (DMPA) and bone mineral density (BMD) has been controversial, as seen in three case-control studies in New Zealand, Thailand, and the United Kingdom. In the present case-controlled study of BMD, a group of 67 Chinese women who had used DMPA from 5-15 years was compared with 218 women of the same age range who had not used any steroidal hormones. DMPA users were found to have a significantly lower BMD at lumbar vertebra (L2-4) (0.93 g/cm2), neck of femur (0.69 g/cm2), trochanter (0.59 g/cm2), and Ward's triangle (0.58 g/cm2), as compared with the control group, whose corresponding BMD values were 1.03 g/cm2, 0.83 g/cm2, 0.71 g/cm2, and 0.78 g/cm2, respectively (p < 0.001). The average percentage of bone loss per year was estimated to be 1.1% in L2-4, 2.3% in neck of femur, 2.4% in trochanter, and 3.5% in Ward's triangle. The percentage of bone loss in L2-4 was found to be more pronounced with age. This study provided information that the use of DMPA in a Chinese group for > 5 years in associated with bone loss, and a prospective study is needed to confirm these data, which are different from two case-control studies.
KW - Absorptiometry, Photon
KW - Adult
KW - Age Factors
KW - Amenorrhea
KW - Body Mass Index
KW - Bone Density: drug effects
KW - Bone Resorption: etiology
KW - Calcium: metabolism
KW - Case-Control Studies
KW - China
KW - Contraceptive Agents, Female: pharmacology
KW - Female
KW - Femur: physiopathology
KW - Humans
KW - Lumbar Vertebrae: physiopathology
KW - Medroxyprogesterone Acetate: pharmacology
KW - Middle Aged
KW - Questionnaires
KW - Regression Analysis
KW - Contraceptive Agents, Female (NLM Chemicals)
KW - Medroxyprogesterone Acetate (NLM Chemicals)
KW - Calcium (NLM Chemicals)
KW - J (WoSType)
LB - PUB:(DE-HGF)16
C6 - pmid:10342083
UR - <Go to ISI:>//WOS:000294471600004
DO - DOI:10.1007/s00767-011-0169-6
UR - https://juser.fz-juelich.de/record/17016
ER -